이지바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 브이아이피자산운용, was filed 08 Jun 2026.
이지바이오: what insiders have been doing
이지바이오 is a Food & Beverage company. Its directors and officers file their transactions with DART (FSS). 2 insiders have disclosed 2 filings since 2 November 2025.
The flow runs one way only: 1 insider bought (1 purchase) and nobody sold on the market. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 1 major shareholder.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 2 filings, this issuer sits below that mark. Our records for 이지바이오 go back to 2021, with 23 purchases and no sales on the open market in total.
The most recent open-market purchase was published on 8 June 2026, 155 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Davide Campari - Milano N.V. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -16.3%Entry ₩4,140 · Close at T+365 ₩3,465
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 1,752,374 sharesKRXDART:20260608000288Canonical exit: 6 Sept 2026 (T+90)
- ●Executives0DART
- 10,000 sharesShareKRXDART:20250609000221Canonical exit: 7 Sept 2025 (T+90)
- ShareKRXDART:20240904000436Canonical exit: 26 Nov 2024 (T+90)
- 663,342 sharesKRXDART:20231219000337Canonical exit: 13 Mar 2024 (T+90)
- ShareKRXDART:20231219000340Canonical exit: 11 Mar 2024 (T+90)
- ●Executives0DART
- ShareKRXDART:20231208000377Canonical exit: 7 Mar 2024 (T+90)
- ShareKRXDART:20231208000375Canonical exit: 7 Mar 2024 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 43,399 sharesKRXDART:20230110000693Canonical exit: 10 Apr 2023 (T+90)
- 43,399 shares@ ₩3,945.2712100.0% of flowShareKRXDART:20230110000700Canonical exit: 29 Mar 2023 (T+90)
- 244,802 sharesKRXDART:20221222000488Canonical exit: 22 Mar 2023 (T+90)
- ShareKRXDART:20221222000493Canonical exit: 22 Mar 2023 (T+90)
- 486,509 sharesKRXDART:20221212000345Canonical exit: 12 Mar 2023 (T+90)
- ShareKRXDART:20221212000352Canonical exit: 12 Mar 2023 (T+90)
- 419,789 sharesKRXDART:20221130001941Canonical exit: 28 Feb 2023 (T+90)
- ShareKRXDART:20221130001950Canonical exit: 28 Feb 2023 (T+90)
- 395,433 sharesKRXDART:20221013000453Canonical exit: 11 Jan 2023 (T+90)
- ShareKRXDART:20221013000456Canonical exit: 11 Jan 2023 (T+90)
- ●Executives0DART
25 of 39 declarations
About 이지바이오
이지바이오 is a company in the agro-food sector listed on the XKRX market. It specializes in the production and distribution of organic products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
